ORIENTBIO Inc. (002630) — Cash Flow Quality Index
ORIENTBIO Inc. (002630) has a Cash Flow Quality Index of 0.12x as of March 2024. Operating cash flow of ₩1.35 Billion is below net income of ₩10.99 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore ORIENTBIO Inc. long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ORIENTBIO Inc. Cash Flow Quality Index (2007–2024)
Historical Cash Flow Quality Index for ORIENTBIO Inc. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of ORIENTBIO Inc. to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ORIENTBIO Inc. (2007–2024)
Year-by-year earnings quality comparison for ORIENTBIO Inc.. For live market cap and the full company financial profile, see market value of ORIENTBIO Inc..
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩3.76 Billion | ₩12.87 Billion | ▲ +324.5% |
| 2022 | 0.07x | ₩2.35 Billion | ₩34.20 Billion | ▼ -98.8% |
| 2013 | 5.80x | ₩5.09 Billion | ₩878.82 Million | ▲ +656.8% |
| 2011 | 0.77x | ₩3.11 Billion | ₩4.07 Billion | ▼ -73.4% |
| 2007 | 2.88x | ₩1.52 Billion | ₩526.73 Million | — |